Soligenix
SNGX
$0.42
Share price
-2.81%
Change (1 day)
-73.05%
Change (1 year)
Categories
Operating Margin for Soligenix (SNGX)
Operating Margin as of April 2024 (TTM): -1,627.59%
According to Soligenix's latest financial reports and stock price the company's current Operating Margin is -1,627.59%. At the end of 2021 the company had an Operating Margin of -1,627.59%.
Operating Margin history for Soligenix from 2001 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -1,627.59% | 107.29% |
| 2020 | -785.16% | 264.75% |
| 2019 | -215.26% | 26.77% |
| 2018 | -169.80% | 21.95% |
| 2017 | -139.23% | 285.33% |
| 2016 | -36.13% | -61.92% |
| 2015 | -94.89% | -8.75% |
| 2014 | -103.99% | -68.98% |
| 2013 | -335.26% | 125.06% |
| 2012 | -148.97% | 286.59% |
| 2011 | -38.53% | -90.17% |
| 2010 | -391.88% | 82.37% |
| 2009 | -214.89% | 43.65% |
| 2008 | -149.59% | -70.26% |
| 2007 | -502.94% | 41.88% |
| 2006 | -354.50% | 125.51% |
| 2005 | -157.20% | -73.5% |
| 2004 | -593.21% | -90.49% |
| 2003 | -6,236.06% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 22.88% | -101.41% | 🇺🇸 USA |
 Pfizer PFE | 34.61% | -102.13% | 🇺🇸 USA |
 Sanofi SNY | 18.21% | -101.12% | 🇫🇷 France |
 Onconova Therapeutics ONTX | -8,391.15% | 415.56% | 🇺🇸 USA |
 Athersys ATHX | -1,576.98% | -3.11% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | -20.53% | -98.74% | 🇮🇱 Israel |
 Cleveland BioLabs
CBLI | N/A | N/A | 🇺🇸 USA |
 Emergent BioSolutions
EBS | 17.53% | -101.08% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.